Search

Displaying results 6101 - 6110 of 10000 in total
  1. Drug

    Bos taurus hair

    go.drugbank.com/drugs/DB10856
    Approved

    Bos taurus hair is used in allergenic testing.

    Categories: Non-Standardized Animal Hair Allergenic Extract
  2. Drug

    Capra hircus hair

    go.drugbank.com/drugs/DB10876
    Approved

    Domestic goat hair is used in allergenic testing.

    Categories: Non-Standardized Animal Hair Allergenic Extract
  3. Drug

    Equus caballus hair

    go.drugbank.com/drugs/DB10880
    Approved

    Horse hair is used in allergenic testing.

    Categories: Non-Standardized Animal Hair Allergenic Extract
  4. Drug

    Bos taurus dander

    go.drugbank.com/drugs/DB11020
    Approved

    Bos taurus dander allergenic extract is used in allergenic testing.

    Synonyms: Cow dander, Domestic cow danderCategories: Non-Standardized Animal Dander Allergenic Extract
  5. Indication

    Cutaneous Melanoma

    go.drugbank.com/conditions/DBCOND0040978
    Drugs: Ipilimumab
    Synonyms: Melanoma, NOS, [M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS
  6. Indication

    Melanoma

    go.drugbank.com/conditions/DBCOND0020306
    Drugs: Dabrafenib · Nivolumab · Peginterferon alfa-2b · Trametinib
    Synonyms: Melanoma, NOS, [M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS
  7. Drug

    Tiaramide

    go.drugbank.com/drugs/DB20499
    Experimental

    Tiaramide has a monoisotopic molecular weight of 355.08 Da.

    Categories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-Steroidal
  8. Drug

    Tribromsalan

    go.drugbank.com/drugs/DB20138
    ApprovedWithdrawn

    Tribromsalan has a monoisotopic molecular weight of 446.81 Da.

  9. Drug

    Lubazodone

    go.drugbank.com/drugs/DB09196
    Experimental

    Lubazodone (YM-992, YM-35,995) is an arylpiperazine antidepressant which was being developed as a treatment for depression and obsessive compulsive disorder, and reached phase II clinical trials, but was

  10. Drug

    TTP889

    go.drugbank.com/drugs/DB05131
    Investigational

    TTP889, an orally bioavailable selective inhibitor of the intrinsic coagulation pathway, is being developed as an anticoagulant for the treatment of thromboembolic disorders. TTP889 is the only known selective small molecule inhibitor of...